Literature DB >> 19797193

On the road to iPS cell cardiovascular applications.

Timothy J Kamp, Gary E Lyons.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19797193      PMCID： PMC2771209          DOI： 10.1161/CIRCRESAHA.109.205740

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  28 in total

1.  Generation of induced pluripotent stem cells using recombinant proteins.

Authors:  Hongyan Zhou; Shili Wu; Jin Young Joo; Saiyong Zhu; Dong Wook Han; Tongxiang Lin; Sunia Trauger; Geoffery Bien; Susan Yao; Yong Zhu; Gary Siuzdak; Hans R Schöler; Lingxun Duan; Sheng Ding
Journal:  Cell Stem Cell       Date:  2009-04-23       Impact factor: 24.633

2.  Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Carmen Perez-Terzic; Yasuhiro Ikeda; Andre Terzic
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

3.  iPS cells can support full-term development of tetraploid blastocyst-complemented embryos.

Authors:  Lan Kang; Jianle Wang; Yu Zhang; Zhaohui Kou; Shaorong Gao
Journal:  Cell Stem Cell       Date:  2009-07-23       Impact factor: 24.633

4.  Variation in the safety of induced pluripotent stem cell lines.

Authors:  Kyoko Miura; Yohei Okada; Takashi Aoi; Aki Okada; Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Mari Ohnuki; Daisuke Ogawa; Eiji Ikeda; Hideyuki Okano; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2009-07-09       Impact factor: 54.908

5.  Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents.

Authors:  V A Maltsev; A M Wobus; J Rohwedel; M Bader; J Hescheler
Journal:  Circ Res       Date:  1994-08       Impact factor: 17.367

6.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

7.  Induced pluripotent stem cells from a spinal muscular atrophy patient.

Authors:  Allison D Ebert; Junying Yu; Ferrill F Rose; Virginia B Mattis; Christian L Lorson; James A Thomson; Clive N Svendsen
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

8.  Functional cardiomyocytes derived from human induced pluripotent stem cells.

Authors:  Jianhua Zhang; Gisela F Wilson; Andrew G Soerens; Chad H Koonce; Junying Yu; Sean P Palecek; James A Thomson; Timothy J Kamp
Journal:  Circ Res       Date:  2009-02-12       Impact factor: 17.367

9.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

10.  Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.

Authors:  Danwei Huangfu; Kenji Osafune; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Shuibing Chen; Whitney Muhlestein; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-10-12       Impact factor: 54.908
View more
  11 in total

1.  Right ventricular outflow tract repair with a cardiac biologic scaffold.

Authors:  John M Wainwright; Ryotaro Hashizume; Kazuro L Fujimoto; Nathaniel T Remlinger; Colin Pesyna; William R Wagner; Kimimasa Tobita; Thomas W Gilbert; Stephen F Badylak
Journal:  Cells Tissues Organs       Date:  2011-10-24       Impact factor: 2.481

2.  Recent concepts for the roles of progenitor/stem cell niche in heart repair.

Authors:  Yuliang Feng; Xi-Yong Yu; Yigang Wang
Journal:  Am J Cardiovasc Dis       Date:  2011-12-15

3.  Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment.

Authors:  Yama A Abassi; Biao Xi; Nan Li; Wei Ouyang; Alexander Seiler; Manfred Watzele; Ralf Kettenhofen; Heribert Bohlen; Andreas Ehlich; Eugen Kolossov; Xiaobo Wang; Xiao Xu
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  [Development of vascular and endovascular surgery over the next 20 years].

Authors:  T Schmitz-Rixen; W Lang
Journal:  Chirurg       Date:  2009-12       Impact factor: 0.955

5.  SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del.

Authors:  Jianding Cheng; Ana Morales; Jill D Siegfried; Duanxiang Li; Nadine Norton; Junyao Song; Jorge Gonzalez-Quintana; Jonathan C Makielski; Ray E Hershberger
Journal:  Clin Transl Sci       Date:  2010-12       Impact factor: 4.689

6.  The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine.

Authors:  Ana M Martins; Gordana Vunjak-Novakovic; Rui L Reis
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

7.  Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function.

Authors:  Todd J Herron; Andre Monteiro Da Rocha; Katherine F Campbell; Daniela Ponce-Balbuena; B Cicero Willis; Guadalupe Guerrero-Serna; Qinghua Liu; Matt Klos; Hassan Musa; Manuel Zarzoso; Alexandra Bizy; Jamie Furness; Justus Anumonwo; Sergey Mironov; José Jalife
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-04

8.  In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Justin Davis; Ahmad Chouman; Jeffery Creech; Andre Monteiro da Rocha; Daniela Ponce-Balbuena; Eric N Jimenez Vazquez; Ruthann Nichols; Andrey Lozhkin; Nageswara R Madamanchi; Katherine F Campbell; Todd J Herron
Journal:  JCI Insight       Date:  2021-05-24

Review 9.  Uncovering Inherited Cardiomyopathy With Human Induced Pluripotent Stem Cells.

Authors:  Xue Jiang; Yihuan Chen; Xiaofeng Liu; Lingqun Ye; Miao Yu; Zhenya Shen; Wei Lei; Shijun Hu
Journal:  Front Cell Dev Biol       Date:  2021-05-17

10.  Prospective in vitro models of channelopathies and cardiomyopathies.

Authors:  Nanako Kawaguchi; Emiko Hayama; Yoshiyuki Furutani; Toshio Nakanishi
Journal:  Stem Cells Int       Date:  2012-03-27       Impact factor: 5.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.